Afinitor / Votubia (Everolimus)

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 05/17/2019

Pipeline Type

Newly Marketed

Phase Of Development

Sponsors and Collaborators

Mechanism of Action

Mechanism Description

mTOR Inhibitor

Populations Tested In

Other Resources

Special FDA Designation

Nonprofit or Government Support

N/A

Nonprofit or Government Support Description

N/A

Previous Presentations

Location of Clinical Trials

Clinical Trial link

Join Our Newsletter

Want to get notified about new devices? Stay up to date with the latest epilepsy news and stories from the community.